Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors.
about
Improving Care for Patients With or at Risk for Chronic Kidney Disease Using Electronic Medical Record Interventions: A Pragmatic Cluster-Randomized Trial Protocol.Increased incidence of kidney diseases in general practice after a nationwide albuminuria self-test program.The usefulness of a free self-test for screening albuminuria in the general population: a cross-sectional surveyCharacterizing pre-dialysis care in the era of eGFR reporting: a cohort studyCerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.The influence of chronic renal failure on the spectrum and antimicrobial susceptibility of uropathogens in community-acquired acute pyelonephritis presenting as a positive urine culture.Effect of glycaemic control on glomerular filtration rate in diabetes mellitus patients.Quality of sleep and its relationship to quality of life in hemodialysis patientsMinocycline and doxycycline, but not tetracycline, mitigate liver and kidney injury after hemorrhagic shock/resuscitationPredictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease.Effect of end-stage renal disease on oral health in patients undergoing renal dialysis: A cross-sectional study.Lack of Correlation between Periodontitis and Renal Dysfunction in Systemically Healthy Patients.The effect of exercise training on quality and quantity of sleep and lipid profile in renal transplant patients: a randomized clinical trialPlasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.Role of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension of chronic kidney disease and renoprotection. Study resultsA novel way to monitor urine concentration: fluorescent concentration matrices.Relating illness complexity to reimbursement in CKD patients.Automated clinical reminders for primary care providers in the care of CKD: a small cluster-randomized controlled trialHemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes.Inflammation, diabetes, and chronic kidney disease: role of aerobic capacityAltered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression.Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendationsLeft atrial diameter and albumin with renal outcomes in chronic kidney disease.Haemodialysis practice in a resource-limited setting in the tropics.Retrospective study on prognostic importance of serum procalcitonin and amino-terminal pro-brain natriuretic peptide levels as compared to Acute Physiology and Chronic Health Evaluation IV Score on Intensive Care Unit admission, in a mixed IntensiveThe simplified modification of diet in renal disease equation as a predictor of renal function after coronary artery bypass graft surgery.Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians.Hemodialysis performance and outcomes among end stage renal disease patients from Sokoto, North-Western Nigeria.QT dispersion increases with low glomerular filtration rate in patients with coronary artery disease.A Comparison of Face to Face and Video-Based Self Care Education on Quality of Life of Hemodialysis Patients.Quality of Life of patients with chronic kidney disease in Iran: Systematic Review and Meta-analysis.Management practice, and adherence and its contributing factors among patients with chronic kidney disease at Tikur Anbessa Specialized Hospital: A hospital-based cross-sectional study
P2860
Q30854328-E869099A-AD46-488A-8E3B-7A8657901E94Q31029212-1D7F25E5-727C-4517-B483-C06DD50230F6Q33509637-24F6FCCC-C000-44F3-A211-EE67F68797EEQ33846660-73A68CEC-57DB-406B-9BA7-69EC70940526Q33863368-A8B87C25-DAA6-4E27-BB68-FFF3CB646BB9Q33877975-BBDDC2DA-86F8-4D00-9DD3-A7281EADC891Q33935778-07173D52-DF5E-4262-9D36-A0EFE54FF4A5Q34050330-A6A2B7C8-EDD1-4741-8AF3-3E59207C2A19Q34051444-DCF6A24A-BA45-4E40-A7AB-BE8E1355C536Q34398468-4E343DC8-39DD-4340-B2E3-D87F9541A391Q34405507-0139F52E-A3ED-43D1-9B22-0EE44CB8F640Q34483925-987FD34A-3B9F-40AB-AE3D-8DBD1EDB0BCBQ34567628-EF2F6D02-A686-4645-8FCF-5EEC73A257C2Q34704820-8C17FCBD-AFB5-4B93-885C-7A1016F097F4Q35115546-D2C6A2F1-9877-4288-99C2-A4431A6BD97AQ35139548-01AC0614-A6F4-4AD8-99E2-5602F37DE583Q35547740-2CA1BD7D-1020-4DB8-8D5F-DFF867D43938Q35566672-6F0557F1-3C50-4CF6-97AA-66FA46D8A9FBQ35748710-A8898B70-D08A-4D27-AAB9-F512BA4E650EQ35903666-6BF3515E-06E1-4831-8192-535C20979CEEQ36036109-26C4FD70-6D1B-496B-9D87-FA054C834A0EQ36285948-2BB5C6F5-F82D-4312-85CE-96518CEF788BQ36713424-079B7D1F-124B-4233-8164-1F592A6B2C80Q36818984-F1483E25-D862-4817-B5FF-1610BF65A02DQ36987898-7C396DDE-2B84-4C97-B498-6A9676ED3F97Q37041336-3C3461F2-7E48-492B-986B-1C8C376BE793Q37271690-73DD1E32-16C8-45FD-A1BB-CD423482269CQ37670522-2047AB50-739D-4DC0-9812-1DC5C1A74F00Q37721994-62FF740D-AEB7-4DCD-9FBD-C958872C44FFQ40740939-AE7EF69A-E03A-4DFA-830D-A02611D5BCAFQ49421068-8E3BFBFA-A5C1-43B8-99D9-BDB30A042AC0Q58866156-B08B60EF-A958-4735-BDF9-EB8DF8B4FA6C
P2860
Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical practice guidelines f ...... , treatment, and risk factors.
@ast
Clinical practice guidelines f ...... , treatment, and risk factors.
@en
type
label
Clinical practice guidelines f ...... , treatment, and risk factors.
@ast
Clinical practice guidelines f ...... , treatment, and risk factors.
@en
prefLabel
Clinical practice guidelines f ...... , treatment, and risk factors.
@ast
Clinical practice guidelines f ...... , treatment, and risk factors.
@en
P2093
P1476
Clinical practice guidelines f ...... , treatment, and risk factors.
@en
P2093
Adeera Levin
Andrew S Levey
Cynda Ann Johnson
Garabed Eknoyan
Joseph Lau
P304
P50
P577
2004-09-01T00:00:00Z